Letters to the Editor
July 2002

Mirtazapine in the Treatment of Panic Disorder

Author Affiliations

Copyright 2002 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2002

Arch Gen Psychiatry. 2002;59(7):661-662. doi:10.1001/archpsyc.59.7.661

Mirtazapine has been reported to target symptoms of anxiety (agitation, somatization, psychic anxiety, panic attacks) that often occur in depressed patients.13 Enhancement of both noradrenergic and serotonergic transmission through α autoreceptor and α-heteroreceptor antagonism, respectively, coupled with the blockade of 5-HT2 and 5-HT3 receptors, has been considered the main mechanism of this apparent pharmacological efficacy for anxiety symptoms.3,4 Additionally, H1 receptor antagonism facilitates an initial soporific effect.

First Page Preview View Large
First page PDF preview
First page PDF preview